Evidence map›Paper›PMID 34456966›Full record

ArticleFrontiers in genetics2021

Identification of

Yosr Hamdi, Maroua Boujemaa, Najah Mighri, Nesrine Mejri, Olfa Jaidane, Sonia Ben Nasr, Hanen Bouaziz, Jamel Ben Hassouna, Aref Zribi, Yossra Berrazaga and 10 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 1 country.

Yosr HamdiLaboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.
Maroua BoujemaaLaboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.
Najah MighriLaboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.
Nesrine MejriLaboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.
Olfa JaidaneSurgical Oncology Department, Salah Azaiez Institute of Cancer, Tunis, Tunisia.
Sonia Ben NasrLaboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.
Hanen BouazizLaboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.
Jamel Ben HassounaSurgical Oncology Department, Salah Azaiez Institute of Cancer, Tunis, Tunisia.
Aref ZribiDepartment of Medical Oncology, Military Hospital, Tunis, Tunisia.
Yossra BerrazagaMedical Oncology Department, Abderrahmen Mami Hospital, Ariana, Tunisia.
Haifa RachdiMedical Oncology Department, Abderrahmen Mami Hospital, Ariana, Tunisia.
Nouha DaoudMedical Oncology Department, Abderrahmen Mami Hospital, Ariana, Tunisia.
Houda El BennaMedical Oncology Department, Abderrahmen Mami Hospital, Ariana, Tunisia.
Soumaya LabidiLaboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.
Abderrazek HaddaouiDepartment of Medical Oncology, Military Hospital, Tunis, Tunisia.
Khaled RahalSurgical Oncology Department, Salah Azaiez Institute of Cancer, Tunis, Tunisia.
Farouk BennaDepartment of Radiation Oncology, University of Tunis, Tunis, Tunisia.
Hamouda BoussenLaboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.
Sonia AbdelhakLaboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.
Samir BoubakerLaboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.
Abderrahmane Mami Hospital · TNInstitut Salah-Azaïz · TNTunis El Manar University · TNTunis University · TNInstitut Pasteur de Tunis · TNMilitary Hospital of Tunis · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BRCA2 mutationsbreast cancer susceptibilityCis double heterozygosityearly age of onsetphenotype genotype correlationwhole exome sequencing

Identifiers

PMID34456966
PMCPMC8397457
OpenAlexW3194347689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.